mHealth Apps Market Size To Hit US$ 340.5 Billion By 2030

The global mHealth Apps market size is expected to hit around USD 340.5 billion by 2030 and progressing a CAGR of 26.79% over the forecast period 2022 to 2030.

 

The on mHealth Apps Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1061

Report Scope of the mHealth Apps Market

Report Highlights	Details
Market Size	USD 340.5 Billion by 2030
Growth Rate	CAGR of 26.79% from 2022 to 2030
Fastest Growing Market	Asia Pacific
Largest Market	North America
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Type, Region

A recent report provides crucial insights along with application based and forecast information in the Global MHealth Apps Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the MHealth Apps market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global MHealth Apps market are included as given below:

MHealth Apps Market Key Players

• Abbott Laboratories
• Johnson and Johnson
• AstraZeneca PLC
• Hoffmann-La Roche Ltd.
• Novartis AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Merck and Co., Inc.
• Pfizer, Inc.
• iHealth Labs Inc.
• Vivify Health
• Medtronic MiniMed, Inc.

Market Segments

 By Type

• Nutrition & Diet
• Women's Health
• Medication Adherence
• Fitness
• Lifestyle Management
• Healthcare Providers/Payers
• Disease Management
• Others

By Regional Outlook

• North America
  • The U.S.
  • Canada
• Europe
  • The U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of the World

Report Objectives

• To define, describe, and forecast the global mHealth Apps market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the mHealth Apps market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global mHealth Apps Market, By Type

7.1. mHealth Apps Market, by Type, 2020-2030
7.1.1. Nutrition & Diet
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Women's Health
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medication Adherence
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Fitness
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Lifestyle Management
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Healthcare Providers/Payers
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Disease Management
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global mHealth Apps Market, Regional Estimates and Trend Forecast

8.1. North America
8.1.1. Market Revenue and Forecast, by Type (2017-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Type (2017-2030)

Chapter 9. Company Profiles

9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Johnson and Johnson
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AstraZeneca PLC
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Hoffmann-La Roche Ltd.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Novartis AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. GlaxoSmithKline plc
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Merck and Co., Inc.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Pfizer, Inc.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. iHealth Labs Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Vivify Health
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Medtronic MiniMed, Inc.
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives

Chapter 10. Research Methodology

10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions

Chapter 11. Appendix

11.1. About Us
11.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com